Skip to content
Recall Observatory FDA recall evidence

Drug product

Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 50111-647-01, UPC 3 50111-647-01 5.

D-1281-2014

February 12, 2014

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 67563
Status
Terminated
Classification
Class II
Quantity
72,356 bottles
Official record key
drug-enforcement:D-1281-2014

Official wording

Reason: Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.

Code information: Lot #: 6A211158, 6A211159, 6A211163, Exp 11/15

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Chemical Contamination